Studies have demonstrated the effectiveness of somatostatin and methionine-enkephalin in antagonizing VIP’s diarrheagenic activity when delivered intra-arterially [48], but the intestinal intra-arterial route is not clinically feasible, and intravenous administration of somatostatin had no effect on stool output in cholera patients [49]. This evidence concerns the gene SST and vibrio infectious disease.